LTFS
PBYI icon

Ladenburg Thalmann Financial Services’s Puma Biotechnology PBYI Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$45K Buy
5,168
+3,497
+209% +$28.9K ﹤0.01% 3598
2019
Q3 		$18K Buy
1,671
+199
+14% +$2.15K ﹤0.01% 4108
2019
Q2 		$19K Sell
1,472
-697
-32% -$16.1K ﹤0.01% 4088
2019
Q1 		$85K Buy
2,169
+1,556
+254% +$47.5K ﹤0.01% 3004
2018
Q4 		$12K Sell
613
-78
-11% -$2.34K ﹤0.01% 4180
2018
Q3 		$32K Sell
691
-856
-55% -$41.3K ﹤0.01% 3612
2018
Q2 		$105K Hold
1,547
– – ﹤0.01% 2718
2018
Q1 		$105K Buy
1,547
+1,167
+307% +$87.4K ﹤0.01% 2718
2017
Q4 		$38K Buy
380
+6
+2% +$671 ﹤0.01% 3411
2017
Q3 		$45K Hold
374
– – ﹤0.01% 3154
2017
Q2 		$33K Hold
374
– – ﹤0.01% 3296
2017
Q1 		$14K Hold
374
– – ﹤0.01% 3779
2016
Q4 		$11K Buy
374
+300
+405% +$13K ﹤0.01% 3834
2016
Q3 		$5K Hold
74
– – ﹤0.01% 4167
2016
Q2 		$2K Hold
74
– – ﹤0.01% 4420
2016
Q1 		$2K Sell
74
-225
-75% -$10.2K ﹤0.01% 4398
2015
Q4 		$23K Sell
299
-410
-58% -$32.2K ﹤0.01% 3123
2015
Q3 		$54K Buy
709
+50
+8% +$4.73K ﹤0.01% 2410
2015
Q2 		$77K Sell
659
-49
-7% -$8.87K ﹤0.01% 2290
2015
Q1 		$167K Buy
708
+9
+1% +$1.92K ﹤0.01% 1707
2014
Q4 		$132K Sell
699
-257
-27% -$57K ﹤0.01% 1707
2014
Q3 		$228K Buy
956
+902
+1,670% +$185K 0.01% 1152
2014
Q2 		$4K Buy
54
+47
+671% +$3.34K ﹤0.01% 3460
2014
Q1 		$1K Buy
+7
New +$823 ﹤0.01% 3641

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ladenburg Thalmann Financial Services's PBYI Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Puma Biotechnology (PBYI) stake by 209% in Q4 2019, buying an estimated $28.9K and bringing the position to 5,168 shares worth $45K. The position accounts for ﹤0.01% of the portfolio, ranked #3598.

Ladenburg Thalmann Financial Services first reported a position in PBYI in Q1 2014 and has held it in 24 quarters since. The position peaked at $228K in Q3 2014. 133 funds tracked by Wall St. Rank hold PBYI as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 5,168 shares of Puma Biotechnology worth $45K as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 3,497 Puma Biotechnology shares in Q4 2019, an estimated $28.9K.
  • Puma Biotechnology made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3598 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Puma Biotechnology in Q1 2014 and has held it in 24 quarters since.
  • Ladenburg Thalmann Financial Services's Puma Biotechnology position peaked at $228K in Q3 2014.
  • 133 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.